Fight AIDS Foundation

DeepTech applied to the development of new and accessible treatments for COVID-19 to stop its expansion and fight new variants.

The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients.

A recent study shows differences in quality of life related to health among people with HIV according to their gender.

The Fight AIDS Foundation has developed a website where health professionals can share clinical cases about drug interactions in real life.

The final results of the PARTNER study are now published in the leading medical journal The Lancet. The study reports zero HIV transmissions over eight years in gay men not using condoms, finally confirming that an undetectable ...

A study indicates for the first time defects in the protein of the external membrane of the HIV that would explain that 5 patients have been able to control the virus for more than 25 years without need of ...

At the Fight AIDS Foundation there is a research line in this area that, in addition to studying its specific field, collaborates in the development of other projects.

Dr. Josep M. Llibre is the first author of this paper on simplification of antiretroviral treatment.

Information on the president of the Fight AIDS Foundation.

AELIX-002 phase I study will focus on evaluating the safety and immunogenicity of the HTI vaccine.